Applied BioCode (TPE:6598) Cyclically Adjusted PB Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6598 Applied BioCode Corp TPE:6598
74 GF Score
Price NT$28.80
GF Value NT$27.79
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Applied BioCode Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Applied BioCode  (TPE:6598) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Applied BioCode Cyclically Adjusted PB Ratio Related Terms


Applied BioCode Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Applied BioCode's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied BioCode Cyclically Adjusted PB Ratio Chart

Applied BioCode Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Applied BioCode Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.25

TPE:6598 vs ABT, SYK, MDT: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Applied BioCode's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied BioCode Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Applied BioCode's Cyclically Adjusted PB Ratio falls into.


TPE:6598
74GF Score
Applied BioCode Corp TPE:6598
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied BioCode Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Applied BioCode's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 is calculated as:

For example, Applied BioCode's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book=Book Value per Share/CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.44/330.2130*330.2130
=6.440

Current CPI (Mar. 2026) = 330.2130.

Applied BioCode Quarterly Data

Book Value per Share CPI Adj_Book
201212 0.000 229.601 0.000
201312 6.075 233.049 8.608
201412 11.219 234.812 15.777
201512 0.000 236.525 0.000
201606 10.871 241.018 14.894
201612 8.504 241.432 11.631
201706 5.229 244.955 7.049
201712 5.100 246.524 6.831
201806 2.925 251.989 3.833
201809 0.000 252.439 0.000
201812 6.585 251.233 8.655
201903 0.000 254.202 0.000
201906 4.295 256.143 5.537
201909 7.477 256.759 9.616
201912 6.938 256.974 8.915
202003 6.368 258.115 8.147
202006 12.753 257.797 16.335
202009 12.271 260.280 15.568
202012 12.583 260.474 15.952
202103 12.335 264.877 15.378
202106 11.452 271.696 13.918
202109 10.765 274.310 12.959
202112 10.441 278.802 12.366
202203 9.926 287.504 11.401
202206 9.973 296.311 11.114
202209 10.122 296.808 11.261
202212 9.432 296.797 10.494
202303 8.790 301.836 9.616
202306 8.282 305.109 8.963
202309 8.072 307.789 8.660
202312 7.639 306.746 8.223
202403 7.143 312.332 7.552
202406 6.669 314.175 7.009
202409 8.937 315.301 9.360
202412 8.550 315.605 8.946
202503 8.310 319.799 8.581
202506 6.903 322.561 7.067
202509 6.688 324.800 6.799
202512 6.256 324.054 6.375
202603 6.440 330.213 6.440

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be overvalued. The current stock price of NT$28.80 is trading 3.6% above its estimated GF Value™ of NT$27.79. GuruFocus considers Applied BioCode to be Fairly Valued.

Key valuation signals for TPE:6598:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$27.79 vs. price of NT$28.80 (3.6% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Applied BioCode Business Description

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score

Get the complete analysis for TPE:6598

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.80
Price
NT$27.79
GF Value